Turning to the fourth quarter, results were in line with our expectations. During the fourth quarter, our digital segment delivered an all-time quarterly EBITDA record of $85,000,000 despite ...
Michael H. Carrel: 2025 was an exceptional year at AtriCure, Inc. with achievements across our business. This trial is evaluating the benefit of our AtriClip devices on non-AFib patients undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results